Applying Continuous Improvement (CI) Manufacturing - - BioPharm International

ADVERTISEMENT

Applying Continuous Improvement (CI) Manufacturing


BioPharm International


5. Knowledge TransferThe final principle in Lonza's CI philosophy is the transfer of key learning and knowledge to other systems, processes, and people. Transferring information can potentially prevent the same issue from occurring in other departments or facilities. This transfer of information helps reduce the resources that other departments and facilities spend trying to resolve the same or similar issues. This has been particularly beneficial where multiple facilities perform similar operations.

Due to the success of the manufacturing CI leads over the last 12 months, two new positions for engineering CI leads have been established at Lonza's UK operations. After a 10-month secondment, the two initial manufacturing CI leads moved to work on Six Sigma Black Belt projects and were recently replaced by two new manufacturing CI leads. Despite the relatively short time that the CI lead role has existed, the benefits of having dedicated resources are clear. Lonza is convinced that this investment in dedicated resources has produced and will continue to produce real returns in improved operational efficiency and effectiveness.

References1. Wise SA, Fair DC. Innovative control charting: practical SPC solutions for today's manufacturing environment. Milwaukee (WI): ASQ Quality Press; 1988.

2. London A. BioPharma Operations Excellence. BioPharm International 2003; 16:18-19.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here